K&L Gates Advises Axonics on $138 Million IPO
21 November 2018
Michael A. Hedge
- Global law firm
K&L Gates LLP
has advised medical technology company Axonics Modulation Technologies, Inc. on its successful initial public offering of 9.2 million shares of common stock, raising $138 million in gross proceeds before underwriting discounts, commissions, and offering expenses.
Axonics’ common stock began trading on The Nasdaq Global Select Market under the ticker symbol “AXNX” on October 31, 2018.
The K&L Gates team that advised Axonics was led by Orange County managing partner Michael Hedge. Other key team members from K&L Gates include food, drugs, medical devices and cosmetics partner Michael Hinckle, employee benefits partner Matthew Jones, and corporate associates Jason Dreibelbis, Alexa Ekman, and Hillary O’Rourke.
Back to Mobile Web Home
View Full Site
Back to Top
2019 K&L Gates LLP. All Rights Reserved.
Attorney advertising. Prior results do not guarantee a similar outcome.